Clinical Trials Logo

Hook Worm clinical trials

View clinical trials related to Hook Worm.

Filter by:
  • None
  • Page 1

NCT ID: NCT04844905 Recruiting - Malaria,Falciparum Clinical Trials

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

MATAMAL
Start date: May 3, 2021
Phase: Phase 3
Study type: Interventional

This is a cluster-randomized placebo-controlled clinical trial to evaluate the additive benefit of Ivermectin (IVM) (or Placebo) mass drug administration (MDA) to dihydroartemisinin-piperaquine (DP) MDA for malaria control in a moderate to low malaria-endemic setting as an adjunctive strategy to existing programmatic malaria control measures. The regime of DP and IVM will target both human reservoirs of Plasmodium falciparum and the Anopheles gambiae vector respectively, with the aim of interrupting transmission. The trial will be conducted on the Bijagos Archipelago, where islands (clusters) will be randomised to receive seasonal DP and IVM or DP and Placebo MDA. The primary outcome will be the prevalence of infection with Plasmodium falciparum in all age groups detected by nucleic acid amplification testing during the peak malaria transmission season after two years of intervention.